Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) has been implicated as a major mutagenic heterocyclicamine in the human diet and is carcinogenic in the rat prostate. To validate PhIP-induced rat prostatic neoplasia as a model of human prostate cancer progression, we sought to study the earliest histologic and morphologic changes in the prostate and to follow progressive changes over time. We fed sixty-seven 5-week-old male Fischer F344 rats with PhIP (400 ppm) or control diets for 20 weeks, and then sacrificed animals for histomorphologic examination at the ages of 25, 45, and 65 weeks. Animals treated with PhIP showed significantly more inflammation (P = .002, > .001, and .016 for 25, 45, and 65 weeks, respectively) and atrophy (P = .003, > .001, and .006 for 25, 45, and 65 weeks, respectively) in their prostate glands relative to controls. Prostatic intraepithelial neoplasia (PIN) occurred only in PhIP-treated rats. PIN lesions arose in areas of glandular atrophy, most often in the ventral prostate. Atypical cells in areas of atrophy show loss of glutathione S-transferase π immunostaining preceding the development of PIN. None of the animals in this study developed invasive carcinomas, differing from those in previous reports. Overall, these findings suggest that the pathogenesis of prostatic neoplasia in the PhIP-treated rat prostate proceeds from inflammation to postinflammatory proliferative atrophy to PIN.

Original languageEnglish (US)
Pages (from-to)708-715
Number of pages8
JournalNeoplasia
Volume8
Issue number9
DOIs
StatePublished - 2006

Fingerprint

Atrophy
Prostatic Intraepithelial Neoplasia
Inflammation
Prostate
Neoplasms
Inbred F344 Rats
Diet
2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine
Glutathione Transferase
Prostatic Neoplasms
Carcinoma

Keywords

  • PhIP carcinogen
  • Prostate cancer
  • Prostate inflammation
  • Prostatic intraepithelial neoplasia
  • Rat model

ASJC Scopus subject areas

  • Cancer Research

Cite this

Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model. / Borowsky, Alexander D; Dingley, Karen H.; Ubick, Esther; Turteltaub, Ken W; Cardiff, Robert; deVere White, Ralph W.

In: Neoplasia, Vol. 8, No. 9, 2006, p. 708-715.

Research output: Contribution to journalArticle

@article{73afe929d77044a1a591446431a16df6,
title = "Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model",
abstract = "2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) has been implicated as a major mutagenic heterocyclicamine in the human diet and is carcinogenic in the rat prostate. To validate PhIP-induced rat prostatic neoplasia as a model of human prostate cancer progression, we sought to study the earliest histologic and morphologic changes in the prostate and to follow progressive changes over time. We fed sixty-seven 5-week-old male Fischer F344 rats with PhIP (400 ppm) or control diets for 20 weeks, and then sacrificed animals for histomorphologic examination at the ages of 25, 45, and 65 weeks. Animals treated with PhIP showed significantly more inflammation (P = .002, > .001, and .016 for 25, 45, and 65 weeks, respectively) and atrophy (P = .003, > .001, and .006 for 25, 45, and 65 weeks, respectively) in their prostate glands relative to controls. Prostatic intraepithelial neoplasia (PIN) occurred only in PhIP-treated rats. PIN lesions arose in areas of glandular atrophy, most often in the ventral prostate. Atypical cells in areas of atrophy show loss of glutathione S-transferase π immunostaining preceding the development of PIN. None of the animals in this study developed invasive carcinomas, differing from those in previous reports. Overall, these findings suggest that the pathogenesis of prostatic neoplasia in the PhIP-treated rat prostate proceeds from inflammation to postinflammatory proliferative atrophy to PIN.",
keywords = "PhIP carcinogen, Prostate cancer, Prostate inflammation, Prostatic intraepithelial neoplasia, Rat model",
author = "Borowsky, {Alexander D} and Dingley, {Karen H.} and Esther Ubick and Turteltaub, {Ken W} and Robert Cardiff and {deVere White}, {Ralph W}",
year = "2006",
doi = "10.1593/neo.06373",
language = "English (US)",
volume = "8",
pages = "708--715",
journal = "Neoplasia (United States)",
issn = "1522-8002",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model

AU - Borowsky, Alexander D

AU - Dingley, Karen H.

AU - Ubick, Esther

AU - Turteltaub, Ken W

AU - Cardiff, Robert

AU - deVere White, Ralph W

PY - 2006

Y1 - 2006

N2 - 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) has been implicated as a major mutagenic heterocyclicamine in the human diet and is carcinogenic in the rat prostate. To validate PhIP-induced rat prostatic neoplasia as a model of human prostate cancer progression, we sought to study the earliest histologic and morphologic changes in the prostate and to follow progressive changes over time. We fed sixty-seven 5-week-old male Fischer F344 rats with PhIP (400 ppm) or control diets for 20 weeks, and then sacrificed animals for histomorphologic examination at the ages of 25, 45, and 65 weeks. Animals treated with PhIP showed significantly more inflammation (P = .002, > .001, and .016 for 25, 45, and 65 weeks, respectively) and atrophy (P = .003, > .001, and .006 for 25, 45, and 65 weeks, respectively) in their prostate glands relative to controls. Prostatic intraepithelial neoplasia (PIN) occurred only in PhIP-treated rats. PIN lesions arose in areas of glandular atrophy, most often in the ventral prostate. Atypical cells in areas of atrophy show loss of glutathione S-transferase π immunostaining preceding the development of PIN. None of the animals in this study developed invasive carcinomas, differing from those in previous reports. Overall, these findings suggest that the pathogenesis of prostatic neoplasia in the PhIP-treated rat prostate proceeds from inflammation to postinflammatory proliferative atrophy to PIN.

AB - 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP) has been implicated as a major mutagenic heterocyclicamine in the human diet and is carcinogenic in the rat prostate. To validate PhIP-induced rat prostatic neoplasia as a model of human prostate cancer progression, we sought to study the earliest histologic and morphologic changes in the prostate and to follow progressive changes over time. We fed sixty-seven 5-week-old male Fischer F344 rats with PhIP (400 ppm) or control diets for 20 weeks, and then sacrificed animals for histomorphologic examination at the ages of 25, 45, and 65 weeks. Animals treated with PhIP showed significantly more inflammation (P = .002, > .001, and .016 for 25, 45, and 65 weeks, respectively) and atrophy (P = .003, > .001, and .006 for 25, 45, and 65 weeks, respectively) in their prostate glands relative to controls. Prostatic intraepithelial neoplasia (PIN) occurred only in PhIP-treated rats. PIN lesions arose in areas of glandular atrophy, most often in the ventral prostate. Atypical cells in areas of atrophy show loss of glutathione S-transferase π immunostaining preceding the development of PIN. None of the animals in this study developed invasive carcinomas, differing from those in previous reports. Overall, these findings suggest that the pathogenesis of prostatic neoplasia in the PhIP-treated rat prostate proceeds from inflammation to postinflammatory proliferative atrophy to PIN.

KW - PhIP carcinogen

KW - Prostate cancer

KW - Prostate inflammation

KW - Prostatic intraepithelial neoplasia

KW - Rat model

UR - http://www.scopus.com/inward/record.url?scp=33749064225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749064225&partnerID=8YFLogxK

U2 - 10.1593/neo.06373

DO - 10.1593/neo.06373

M3 - Article

VL - 8

SP - 708

EP - 715

JO - Neoplasia (United States)

JF - Neoplasia (United States)

SN - 1522-8002

IS - 9

ER -